You know i screen shot many moments over the last year and
You know i screen shot many moments over the last year and a half going on 2 yrs now that I thought was fishy regarding purchases, sells and my own shares action. I am sure if others cross referenced their activity with mine, we all see the same picture its a freaking mess! I am not an expert at stocks or even at an intermediate level. I am a bookkeeper so numbers stick out for me. Now that the 13D has officially started their public process on paper, we are finally sitting where we need to be on SP with what we have accomplished. By no means that this is where we will stay. I have also had many friends and families invest between 2 to 7 dollars they are HOLDING but not losing unless they sell. I sat at a 53 cent average until I bought more later. We are not worried if we stay with our BOD and Management team. I sure hope that we win in the end. This is not something that just occurred randomly as a plan with the 13D it has been building to put them where they are now. IMHO they will be exposed and it will end at voting. Long shareholders have been paying attention for a long time and just now been able to put the missing puzzle pieces together! Keep up the good work people and thank you, the rest need to sit back shut up and just listen.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...
Continue Reading
Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....
Continue Reading
Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...
Continue Reading
Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...
Continue Reading
Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...
Continue Reading
